SUNDI PHARMA LIMITED
2 JELLICOE GARDENS, JELLICOE GARDENS, STANMORE  HA7 3NS- Active
- Private Limited Company
- Company No. 06538776
- Last Updated: 01 Mar 2024
Company Profile
SUNDI PHARMA LIMITED was incorporated on Wednesday, March 19, 2008 as a Private Limited Company with registered address in STANMORE. SUNDI PHARMA LIMITED has the status: Active and it's listed in the following category: Dispensing chemist in specialised stores. This Private Limited Company has been operating for 16 years 11 months and 6 days.
Name | SUNDI PHARMA LIMITED |
---|---|
Company number | 06538776 |
Company type | Private Limited Company |
Incorporation date | 19 Mar 2008 |
Status | Active |
Industry (SIC 2007) |
Address
Registered Address |
2 JELLICOE GARDENS JELLICOE GARDENS STANMORE HA7 3NS |
---|---|
Country Of Origin |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
Name | Nature of Control |
---|---|
Mrs Dina Karan Kapoor Nationality: British |
Dates: Wednesday, September 15, 2021 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
right to appoint and remove directors
|
Dna Vinodkumar Patel Nationality: British |
Dates: Wednesday, April 6, 2016 - Wednesday, September 15, 2021
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
|
Sunil Vinodkumar Patel Nationality: British |
Dates: Wednesday, April 6, 2016 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
|
Accounts and Confirmation
Type of accounts | UNAUDITED ABRIDGED |
---|---|
End of financial Year | 31 March |
Next annual accounts due | 31 December 2024, (-56 days left) |
Latest accounts | 31 March 2023 |
Next confirmation statement due | 16 April 2017 |
Last confirmation statement dated | 19 March 2016 |
Mortgages
No mortgages have been registered against SUNDI PHARMA LIMITED.
Previous Names
Name | Change Date |
---|---|
SUNDI PHARMA LIMITED | 19 Mar 2008 |